Guardian Pharmacy Services, Inc. carries a market capitalization of 2.65B, placing it among publicly traded companies globally. Its enterprise value stands at 2.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.65B |
| Enterprise Value | 2.61B |
Guardian Pharmacy Services, Inc. currently has 63.33M shares outstanding.
| Shares Outstanding | 63.33M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Guardian Pharmacy Services, Inc. trades at a trailing price-to-earnings ratio of 40.04. The price-to-sales ratio is 1.80, and the price-to-book ratio stands at 10.80.
| PE Ratio | 40.04 |
| PS Ratio | 1.80 |
| PB Ratio | 10.80 |
| P/TBV Ratio | 17.77 |
| P/FCF Ratio | 22.60 |
| P/OCF Ratio | 26.69 |
On an enterprise value basis, Guardian Pharmacy Services, Inc. trades at an EV/EBITDA multiple of 23.98 and an EV/FCF ratio of 22.04. The EV/Sales ratio of 1.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 30.54 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.78 |
| EV / EBITDA | 23.98 |
| EV / EBIT | 30.54 |
| EV / FCF | 22.04 |
Guardian Pharmacy Services, Inc. maintains a current ratio of 1.65, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.68, indicating elevated leverage, while an interest coverage ratio of 172.42 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.65 |
| Quick Ratio | 1.26 |
| Debt / Equity | 13.68 |
| Debt / EBITDA | 0.32 |
| Interest Coverage | 172.42 |
Guardian Pharmacy Services, Inc. posts a return on equity of 31.75 and a return on invested capital of 23.43.
| Return on Equity (ROE) | 31.75 |
| Return on Assets (ROA) | 16.48 |
| Return on Invested Capital (ROIC) | 23.43 |
| Return on Capital Employed (ROCE) | 25.97 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 24.25 |
Over the trailing twelve months, Guardian Pharmacy Services, Inc. has paid 29.29M in income taxes, reflecting an effective tax rate of 30.57.
| Income Tax | 29.29M |
| Effective Tax Rate | 30.57 |
Guardian Pharmacy Services, Inc.'s stock has gained approximately 59.44296% over the past 52 weeks. The 50-day moving average sits at 40.73, while the 200-day moving average is 36.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | 59.44296% |
| 50-Day Moving Average | 40.73 |
| 200-Day Moving Average | 36.73 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Guardian Pharmacy Services, Inc. generated 1.46B in revenue and converted that into 65.91M in net income, yielding earnings per share of 1.05. EBITDA reached 108.80M, while operating income came in at 85.44M.
| Revenue | 1.46B |
| Gross Profit | 316.58M |
| Operating Income | 85.44M |
| Pretax Income | 95.82M |
| Net Income | 65.91M |
| EBITDA | 108.80M |
| EBIT | 85.44M |
| Earnings Per Share (EPS) | 1.05 |
Guardian Pharmacy Services, Inc. holds 89.81M in cash and equivalents against 35.24M in total debt, resulting in a net debt position of -89.81M. Total book value stands at 245.61M, with working capital of 100.63M providing operational flexibility.
| Cash & Cash Equivalents | 89.81M |
| Total Debt | 35.24M |
| Net Debt | -89.81M |
| Equity (Book Value) | 245.61M |
| Book Value Per Share | 3.88 |
| Working Capital | 100.63M |
Guardian Pharmacy Services, Inc. produced 98.86M in operating cash flow over the past twelve months. After subtracting -19.07M in capital expenditures, free cash flow totaled 79.79M - equivalent to 1.27 per share.
| Operating Cash Flow | 98.86M |
| Capital Expenditures | -19.07M |
| Free Cash Flow | 79.79M |
| FCF Per Share | 1.27 |
Guardian Pharmacy Services, Inc. operates with a gross margin of 21.63, reflecting its pricing power and cost economics. The operating margin of 5.84 and net profit margin of 4.50 provide insight into operational efficiency.
| Gross Margin | 21.63 |
| Operating Margin | 5.84 |
| Pretax Margin | 6.55 |
| Profit Margin | 4.50 |
| EBITDA Margin | 7.43 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.19 |
| FCF Yield | 4.43 |
Guardian Pharmacy Services, Inc. posts an Altman Z-Score of 14.34, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.34 |